NIADYNE CORP has a total of 28 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Australia, EPO (European Patent Office) and Mexico. Its main competitors in its focus markets pharmaceuticals, machines and measurement are TAS SINAN, BIOPHARMACOPAE DESIGN INTERNAT and EDKO TRADING REPRESENTATION.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 9 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Mexico | 5 | |
#4 | China | 3 | |
#5 | Hong Kong | 3 | |
#6 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Analysing materials | |
#5 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Jacobson Elaine L | 22 |
#2 | Jacobson Myron K | 22 |
#3 | Kim Moonsun | 14 |
#4 | Kim Hyuntae | 12 |
#5 | Qasem Jaber | 10 |
#6 | Wondrak Georg Thomas | 5 |
#7 | Wondrak Georg T | 4 |
#8 | Cervantes-Laurean Daniel | 4 |
#9 | Qasem Jaber G | 2 |
#10 | Qasem Elaine L Jacobson Myron | 1 |
Publication | Filing date | Title |
---|---|---|
WO0178718A1 | Methods of use of penicillamines for the treatment of conditions resulting from dna damage | |
AU2001253555B2 | Method for identifying regulators of protein-advanced glycation end product (protein-age) formation | |
CN1430513A | Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia | |
AU2001251593B2 | Methods and compositions useful in enhancing oxygen delivery to cells |